Sort
25,944 grants matching “neurodegeneration”
Mechanisms of Neurodegeneration in KIF5A ALS/FTD
$208,170Jonathan Robert Brent · University Of Pittsburgh At Pittsburgh · K08 · FY2025 · NS
BIOMARKERS AND GENETICS CORE
$208,154Joseph F Quinn · Oregon Health & Science University · P30 · FY2011 · AG
How TDP-43 nuclear depletion contributes to aberrant neural activity and ultimately neurodegeneration?
$208,058Yun Li · University Of Wyoming · P20 · FY2022 · GM
Regulation of Sp1-mediated gene transcription in HD
$208,044Massachusetts General Hospital · P01 · FY2004 · NS
Chemotherapy for Huntington's Disease
$208,044Massachusetts General Hospital · P01 · FY2004 · NS
Exercise training in Parkinson's disease: Neural and functional benefits
$208,002Narayanan Krishnamurthi · Arizona State University-Tempe Campus · R21 · FY2009 · HD
Modifiers of Polyglutamine Toxicity
$208,000University Of Michigan At Ann Arbor · K08 · FY2005 · AG
Modifiers of Polyglutamine Toxicity
$208,000Andrew P Lieberman · University Of Michigan At Ann Arbor · K08 · FY2006 · AG
Modifiers of Polyglutamine Toxicity
$208,000University Of Michigan At Ann Arbor · K08 · FY2004 · AG
Detection and structural analysis of misfolded proteins causing neurodegeneration
$207,971David W Colby · University Of Delaware · R00 · FY2012 · NS
Modeling Mutant Profilin 1 Toxicity and ALS in vivo
$207,969Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R21 · FY2013 · NS
ROS driven mitochondrial-telomere dysfunction during environmental stress
$207,928Bennett Van Houten · University Of Pittsburgh At Pittsburgh · R21 · FY2015 · ES
A model of TRPV4 channelopathy
$207,789Charlotte Jane Sumner · Johns Hopkins University · R21 · FY2015 · NS
Core C - Brain Imaging Core
$207,711Richard J Davidson · University Of Wisconsin-Madison · U54 · FY2019 · HD
Core C - Brain Imaging Core
$207,705Richard J Davidson · University Of Wisconsin-Madison · U54 · FY2018 · HD
Project 1 - Cognitive Function and Dementia
$207,688Lisa F Berkman · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2025 · AG
Time-lines of neural degeneration in ALS-PDC mouse model
$207,639Christopher A Shaw · University Of British Columbia · R01 · FY2010 · NS
A modified dietary regiment as a potential novel therapeutic intervention in ALS.
$207,638Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · R21 · FY2008 · AT
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS
$207,627University Of Minnesota Twin Cities · R01 · FY2002 · DA
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
$207,580Yu Luo · University Of Cincinnati · R01 · FY2025 · AG
The role of FGF signaling in suppressing astrogliosis
$207,500Jean M Hebert · Albert Einstein College Of Medicine · R21 · FY2011 · NS
Developing novel nanobody-based biosensors and therapeutics for Huntingtonâs Disease
$207,500Ali Khoshnan · University Of Southern California · R21 · FY2025 · NS
Probing the heterogeneity of brain pericytes using new genetic tools
$207,500Zhen Zhao · University Of Southern California · R21 · FY2025 · AG
Inositol (1,4,5)-trisphosphate receptor proteolysis in ischemic brain injury
$207,360Robert W Neumar · University Of Pennsylvania · R21 · FY2010 · NS
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
$207,281University Of Pittsburgh At Pittsburgh · P01 · FY2002 · NS